Open Door (OTC:OPNDF) Stock, Quote.Headers.trade-ideas

Open Door Inc is engaged in the planning and operation of game content for mobile phones, software development, and content delivery. It is also involved in development and provision of online systems for the internet and mobile phones. The company operates in two sites Travelko, a travel comparison site and GALLERY JAPAN, a japanese traditional art crafts site.

Open Door Inc

Susquehanna analyst James Friedman maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Positive and raises the price target from $230 to $270.

News

Price Target

Analyst Ratings

Susquehanna Maintains Positive on Fiserv, Raises Price Target to $270

WIIM

Bristol-Myers Squibb shares are trading lower. The company announced Phase 2 TRANSCEND FL trial evaluating Breyanzi in adult patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma.

On Monday,&nbsp;Incyte&nbsp;Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) reported&nbsp;fourth-quarter revenue&nbsp;of $1.18 billion, up 16% year over year and beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $1.14 billion</a>.
The company reported an adjusted EPS of $1.43, which was up from $1.06 a year ago and missing the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43588372/incyte-reports-2024-fourth-quarter-and-year-end-financial-results-provides-2025-financial-guidance" rel="noreferrer noopener">consensus estimate of $1.56</a>.
Jakafi&#8217;s net product revenue increased 11% to $773.1 million, primarily due to a 14% increase in paid demand.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42974065/incyte-at-jpm25-eyes-transformational-2025-with-multiple-drug-launches-and-expanding-pipeline" rel="noreferrer noopener">Incyte At JPM25: Eyes Transformational 2025 With Multiple Drug Launches And Expanding Pipeline</a>
Opzelura net product revenue increased 48% to $161.6 million, driven by continued growth in new patient starts and refills in the U.S. and increased contribution from Europe.
Minjuvi/Monjuvi net product revenue increased 265% to $32.81 million, as the company recognized all revenue from sales of Monjuvi in the United States following the acquisition of exclusive global rights for tafasitamab in February 2024.
&#8220;2024 was an important year for Incyte, with a 15% increase in total revenues, driven by strong growth from both Jakafi and Opzelura, as well as significant progress across our R&amp;D pipeline,&#8221; said Hervé Hoppenot, Chief Executive Officer, Incyte.
Guidance: Incyte forecasts 2025 Jakafi revenue of $2.925 billion-$2.975 billion, up 4.76%-6.55% from 2024.
Opzelura sales are expected to increase between 23.9%-31.81% to $630 million-$670 million.
&#8220;Looking ahead to 2025, we anticipate a year of continued strong revenue growth and diversification, as well as several defining milestones that will serve as an inflection point for Incyte. A year ago, we set the goal to achieve more than 10 impactful product launches by 2030. In 2025, a number of key catalysts across the entire portfolio will bring that goal closer to reality,&#8221; Hoppenot added.
Incyte says 2025 is expected to be a year of defining catalysts with four launches, four pivotal study readouts, at least three Phase 3 study initiations, and seven proof-of-concept study readouts.
William Blair writes, &#8220;We continue to see steady growth of Jakafi in approved indications and believe that ongoing studies for lifecycle management could provide upside to current peak sales and offer the potential to extend Jakafi franchise exclusivity. We believe that Opzelura should provide Incyte with an additional meaningful commercial opportunity in large immune dermatological indications. Povorcitinib remains underappreciated by investors and has the potential to be a major value driver by the end of this decade.&#8221;
The analyst Matt Phipps reiterates <a target="_blank" href="https://www.benzinga.com/quote/INCY/analyst-ratings" rel="noreferrer noopener">the Outperform rating</a>.
In November, Incyte&nbsp;announced that it would pause enrollment in the ongoing Phase 2 study of MRGPRX2 (INCB000262) in chronic&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/42069374/incytes-750-million-escient-deal-faces-setback-with-toxicology-issues-in-two-investigational-drugs-analyst-flags-challenges" rel="noreferrer noopener">spontaneous urticaria (CSU)</a>.
The decision was made following the observation of certain in vivo preclinical toxicology findings.
Price Action:&nbsp;INCY stock is down 6.79% at $69.10 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43570221/analysts-see-positive-momentum-for-expedia-on-strong-q4-earnings" target="_blank" rel="noreferrer noopener">Expedia&#8217;s Travel Momentum Grows, But Analysts Await Clearer Signs Of Long-Term Upside</a></li>
</ul>

Analyst Color

Biotech

Earnings

Guidance

Health Care

Movers

General

INCY

Incyte Q4 Earnings: EPS Miss, Strong Jakafi And Opzelura Sales, Says 2025 To Be Catalyst Rich Including 4 Launches

Susquehanna analyst Shyam Patil maintains Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) with a Neutral and raises the price target from $190 to $205.

EXPE

Susquehanna Maintains Neutral on Expedia Group, Raises Price Target to $205

Trading Ideas

DOMH

Dominari Shares Halted On Circuit Breaker To The Upside, Stock Now Up 60.9%

Lyft Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) shares are trading higher Monday following a report indicating the company could launch robotaxis <a href="https://www.benzinga.com/pressreleases/25/01/b43113669/lyft-to-announce-fourth-quarter-and-full-year-2024-financial-results">as soon as 2026</a>. 
What To Know: Lyft is planning to bring a fully autonomous robotaxi service to its app in collaboration with Mobileye Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) as soon as 2026, according to <a href="https://techcrunch.com/2025/02/10/lyft-to-launch-mobileye-powered-robotaxis-as-soon-as-2026-starting-with-dallas/">TechCrunch</a>.
The company plans to test the service in Dallas to start with more markets expected to follow. 
Japanese conglomerate Marubeni will reportedly own and finance the Mobileye-equipped vehicles set to become available for rides on Lyft&#8217;s mobile app. Lyft has not disclosed an OEM partner for the launch or said how many vehicles will be launched in Dallas for the initial rollout. 
The news comes a day ahead of Lyft&#8217;s fourth-quarter financial results. Analysts expect the company to report earnings of 22 cents per share and revenue of $1.56 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43314361/lyft-faces-growing-competition-bank-of-america-analyst-warns#google_vignette">Lyft Faces Growing Competition, Bank of America Analyst Warns</a>
Last quarter, Lyft shares surged after the company reported better-than-expected financial results as gross booking grew 16% year-over-year and active riders and rides reached new all-time highs. 
&#8220;Going forward, our work with best-of-breed partners and the autonomous future we&#8217;re building will give people even more reasons to choose Lyft every time,&#8221; CEO David Risher said at the time.
Lyft guided for full-year 2024 rides growth in the mid-teens on a year-over-year basis, and fourth-quarter gross bookings up 15% to 17%. Adjusted EBITDA is expected to be between $100 million and $105 million in the fourth quarter and full-year free cash flow is expected to exceed $650 million.
LYFT Price Action: <a href="http://benzinga.com/lyft">Lyft shares</a> were up 4.48% at $14.81 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

LYFT

MBLY

Lyft Stock Is Moving Higher Monday: Here's Why

BABA

Alibaba shares are trading higher after President Trump reportedly postponed tariffs on packages under $800 from China.

Scotiabank analyst Jonathan Goldman maintains WSP Global (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WSP#TSX">WSP</a>) with a Sector Outperform and raises the price target from C$279 to C$281.

TSX:WSP

Scotiabank Maintains Sector Outperform on WSP Global, Raises Price Target to C$281

GRCE

Grace Therapeutics shares are trading higher after the company announced its Phase 3 STRIVE-ON safety trial of GTx-104 in aSAH met its primary endpoint. Additionally, the company announced a $30 million private placement.

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, February 10th:
The Greenbrier Companies GBX: This leading supplier of transportation equipment and services to the railroad and related industries carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 13.5% over the last 60 days.
<div class="chart_embed">
<h3>Greenbrier Companies, Inc. (The) Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/GBX/price-consensus-chart?icid=chart-GBX-price-consensus-chart"><img alt="Greenbrier Companies, Inc. (The) Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/ac/1739177989.png" style="height:264px; width:568px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/GBX/price-consensus-chart?icid=chart-GBX-price-consensus-chart">Greenbrier Companies, Inc. (The) price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/GBX?icid=chart-GBX-price-consensus-chart">Greenbrier Companies, Inc. (The) Quote</a>
</div>
Greenbrier has a PEG ratio of 0.94 compared with 1.97 for the industry. The company possesses a <a href="https://www.zacks.com/style-scores-education/">Growth Score</a>&nbsp; of A.
<div class="chart_embed">
<h3>Greenbrier Companies, Inc. (The) PEG Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/GBX/fundamental/peg-ratio-ttm?icid=chart-GBX-fundamental/peg-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/31/1739178886.png&quot; title=&quot;&quot; width=&quot;527&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/GBX/fundamental/peg-ratio-ttm?icid=chart-GBX-fundamental/peg-ratio-ttm">Greenbrier Companies, Inc. (The) peg-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/GBX?icid=chart-GBX-fundamental/peg-ratio-ttm">Greenbrier Companies, Inc. (The) Quote</a>
</div>
Pilgrim&#39;s Pride Corporation PPC: This producer of fresh and frozen meat products carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 2% over the last 60 days.
<div class="chart_embed">
<h3>Pilgrim&#39;s Pride Corporation Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/PPC/price-consensus-chart?icid=chart-PPC-price-consensus-chart"><img alt="Pilgrim's Pride Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/5c/1739178000.png" style="height:264px; width:568px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/PPC/price-consensus-chart?icid=chart-PPC-price-consensus-chart">Pilgrim&#39;s Pride Corporation price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/PPC?icid=chart-PPC-price-consensus-chart">Pilgrim&#39;s Pride Corporation Quote</a>
</div>
Pilgrim&#39;s Pride has a PEG ratio of 0.21 compared with 0.58 for the industry. The company possesses a Growth Score of A.
<div class="chart_embed">
<h3>Pilgrim&#39;s Pride Corporation PEG Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/PPC/fundamental/peg-ratio-ttm?icid=chart-PPC-fundamental/peg-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/d4/1739178899.png&quot; title=&quot;&quot; width=&quot;527&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/PPC/fundamental/peg-ratio-ttm?icid=chart-PPC-fundamental/peg-ratio-ttm">Pilgrim&#39;s Pride Corporation peg-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/PPC?icid=chart-PPC-fundamental/peg-ratio-ttm">Pilgrim&#39;s Pride Corporation Quote</a>
</div>
Pitney Bowes Inc. PBI: This company that&nbsp;provides SaaS shipping solutions, mailing innovation, and financial services carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
<div class="chart_embed">
<h3>Pitney Bowes Inc. Price and Consensus</h3>
<a href="https://www.zacks.com/stock/chart/PBI/price-consensus-chart?icid=chart-PBI-price-consensus-chart"><img alt="Pitney Bowes Inc. Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/d2/1739178025.png" style="height:264px; width:562px" title="" /> </a>
<a href="https://www.zacks.com/stock/chart/PBI/price-consensus-chart?icid=chart-PBI-price-consensus-chart">Pitney Bowes Inc. price-consensus-chart</a> | <a href="https://www.zacks.com/stock/quote/PBI?icid=chart-PBI-price-consensus-chart">Pitney Bowes Inc. Quote</a>
</div>
Pitney Bowes has a PEG ratio of 0.51 compared with 3.05 for the industry. The company possesses a Growth Score of A.
<div class="chart_embed">
<h3>Pitney Bowes Inc. PEG Ratio (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ttm#NYSE">TTM</a>)</h3>
<a href="https://www.zacks.com/stock/chart/PBI/fundamental/peg-ratio-ttm?icid=chart-PBI-fundamental/peg-ratio-ttm">TTM</a>)&quot; height=&quot;250&quot; src=&quot;https://staticx-tuner.zacks.com/images/charts/82/1739178993.png&quot; title=&quot;&quot; width=&quot;527&quot; /&gt;
<a href="https://www.zacks.com/stock/chart/PBI/fundamental/peg-ratio-ttm?icid=chart-PBI-fundamental/peg-ratio-ttm">Pitney Bowes Inc. peg-ratio-ttm</a> | <a href="https://www.zacks.com/stock/quote/PBI?icid=chart-PBI-fundamental/peg-ratio-ttm">Pitney Bowes Inc. Quote</a>
</div>
&nbsp;
See the <a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi%20_1link">full list of top ranked stocks here.</a>
&nbsp;
Learn more about the <a href="https://www.zacks.com/education/stock-scorecard/growth-trading">Growth score and how it is calculated here.</a>
&nbsp;
<h2>Just Released: Zacks Top 10 Stocks for 2025</h2>
Hurry &ndash; you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&amp;P 500&#39;s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. 
&nbsp;
<a href="https://www.zacks.com/registration/top10/welcome/eoffer/5283?adid=SYND_BENZ_ZU_TOP10POST_ZACKS1RANKADDITIONS_269_02102025_2412410&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410" style="font-weight:bold">See New Top 10 Stocks &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ZACKS1RANKADDITIONS_269_2412410&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=PBI&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_269_2412410_PBI&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410">Pitney Bowes Inc. (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/pbi#NYSE">PBI</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=PPC&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_269_2412410_PPC&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410">Pilgrim&#39;s Pride Corporation (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/ppc#NYSE">PPC</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=GBX&amp;ADID=SYND_BENZ_TCK_ZACKS1RANKADDITIONS_269_2412410_GBX&amp;cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410">Greenbrier Companies, Inc. (The) (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/gbx#NYSE">GBX</a>): Free Stock Analysis Report
<a href="https://www.zacks.com/commentary/2412410/best-growth-stocks-to-buy-for-february-10th?cid=CS-BENZ-FT-zacks_1_rank_additions|growth_additions-2412410">To read this article on Zacks.com click here.</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

Equities

Small Cap

Markets

Best Growth Stocks To Buy For February 10th

Essential Props Realty's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPRT#NYSE">EPRT</a>) short percent of float has fallen 4.58% since its last report. The company recently reported that it has 11.69 million shares sold short, which is 9.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.37 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Essential Props Realty Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739201423_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Essential Props Realty has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Essential Props Realty's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Essential Props Realty's peer group average for short interest as a percentage of float is 2.39%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

EPRT

Peering Into Essential Props Realty's Recent Short Interest

EMCOR Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) short percent of float has risen 41.73% since its last report. The company recently reported that it has 695 thousand shares sold short, which is 1.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>EMCOR Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739201417_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for EMCOR Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing EMCOR Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, EMCOR Group's peer group average for short interest as a percentage of float is 5.62%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(EME) - Analyzing EMCOR Group's Short Interest

F5's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NYSE">FFIV</a>) short percent of float has risen 4.28% since its last report. The company recently reported that it has 1.63 million shares sold short, which is 3.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.38 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>F5 Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739201412_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for F5 has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing F5's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, F5's peer group average for short interest as a percentage of float is 6.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

FFIV

Peering Into F5's Recent Short Interest

AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) has outperformed the market over the past 10 years by 3.29% on an annualized basis producing an average annual return of 14.42%. Currently, AECOM has a market capitalization of $14.25 billion. 
Buying $100 In ACM: If an investor had bought $100 of ACM stock 10 years ago, it would be worth $384.51 today based on a price of $107.39 for ACM at the time of writing.
<h3>AECOM's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739201409_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

CORRECTION :JMP Securities analyst Matthew Carletti reiterates Skyward Specialty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKWD#NASDAQ">SKWD</a>) with a Market Outperform and raises the price target from $53 to $60.((Change in price target from from $53 to $60)

Reiteration

SKWD

CORRECTION : JMP Securities Reiterates Market Outperform on Skyward Specialty, Raises Price Target to $60 (Change in price target from from $53 to $60)

Scotiabank analyst Patrick Colville maintains SolarWinds (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWI#NYSE">SWI</a>) with a Sector Perform and raises the price target from $15 to $18.5.

Scotiabank Maintains Sector Perform on SolarWinds, Raises Price Target to $18.5

<a href="https://x.com/AFP/status/1888955702896431214" title="https://x.com/AFP/status/1888955702896431214">https://x.com/AFP/status/1888955702896431214</a>

Politics

iShares MSCI Israel Capped Investable Market Index Fund

President Trump Says 'No Right Of Return' For Palestinians Under Gaza Takeover Plan

BOOM

DMC Global shares are trading higher after the company announced a non-binding acquisition proposal from Steel Connect

The rise of artificial intelligence (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ai#NYSE">AI</a>) and cloud computing has revolutionized business operations while also increasing cybersecurity risks. As threats become more advanced, AI-driven security solutions are now crucial for safeguarding sensitive data, preventing breaches and detecting fraud in real-time.
This shift has positioned AI-powered cybersecurity as a key long-term investment theme, driving growth opportunities for leading companies like CrowdStrike CRWD &amp; Cloudflare Inc NET.
<h2>What is Cloud AI?</h2>
Cloud AI refers to AI tools and services that run on cloud computing platforms like Google Cloud, which is part of Google&#39;s parent company, Alphabet Inc. GOOGL; Amazon Web Services (AWS), a division of Amazon AMZN; and Microsoft Azure, a division of Microsoft MSFT. Instead of installing software on a personal computer or a company&#39;s servers, businesses can use AI-powered tools hosted in the cloud to analyze massive amounts of data, detect anomalies and make security decisions.
<h2>How AI is Revolutionizing Cybersecurity</h2>
Traditional cybersecurity tools rely on rules and signatures to detect threats, which means they need to be updated regularly to recognize new attacks. However, cybercriminals are constantly finding new ways to break into systems. AI-powered cybersecurity, on the other hand, learns and adapts to new threats without human intervention.
To highlight some of the key benefits, AI-powered cybersecurity enables real-time threat detection, instantly identifying suspicious activities within networks to prevent data breaches before they occur. AI can also take immediate action through automated incident response, such as blocking malicious connections or isolating compromised systems without human intervention. Additionally, AI plays a crucial role in fraud prevention, detecting fraudulent activities in banking, e-commerce and online transactions with high accuracy. One of its most significant advantages is zero-day attack defense, where AI identifies and mitigates never-before-seen cyber threats, ensuring proactive security against evolving cyber risks.
<h2>Bet on Two AI Cybersecurity Leaders: CRWD &amp; NET</h2>
Considering the backdrop, investors should include these two AI Cybersecurity stocks in their portfolios.
CrowdStrike
CrowdStrike&#39;s AI-native cybersecurity platform enables businesses and governments to proactively detect and stop cyber threats before they escalate. Its cloud-based Falcon platform integrates AI-driven threat intelligence, identity protection and next-gen SIEM, driving rapid enterprise adoption. With increasing consolidation of security tools and growing demand for AI-powered protection, CrowdStrike is positioned as a leader in modern cybersecurity transformation. The stock currently carries a Zacks Rank #2 (Buy). You can see&nbsp;<a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link_invideas&amp;ICID=zpi_1link_invideas">the complete list of today&#39;s Zacks #1 Rank (Strong Buy) stocks here</a>.
Cloudflare
Cloudflare leverages AI-driven security to protect global enterprises, including government agencies, from evolving cyber threats. Its platform mitigates DDoS attacks, enhances Zero Trust architecture and delivers high-performance AI-powered security. With a scalable, efficient network and increasing enterprise adoption, #2 Ranked Cloudflare is positioned for long-term growth as cybersecurity, AI and digital modernization remain top enterprise priorities.
&nbsp;
<h2>Just Released: Zacks Top 10 Stocks for 2025</h2>
Hurry &ndash; you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&amp;P 500&#39;s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. 
&nbsp;
<a href="https://www.zacks.com/registration/top10/welcome/eoffer/5283?adid=SYND_BENZ_ZU_TOP10POST_ANALYSTBLOG_215_IND_02102025_2412571&amp;cid=CS-BENZ-FT-analyst_blog|investment_ideas-2412571" style="font-weight:bold">See New Top 10 Stocks &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ANALYSTBLOG_215_2412571&amp;cid=CS-BENZ-FT-analyst_blog|investment_ideas-2412571" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=AMZN&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_215_2412571_AMZN&amp;cid=CS-BENZ-FT-analyst_blog|investment_ideas-2412571">Amazon.com, Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=MSFT&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_215_2412571_MSFT&amp;cid=CS-BENZ-FT-analyst_blog|investment_ideas-2412571">Microsoft Corporation (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=GOOGL&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_215_2412571_GOOGL&amp;cid=CS-BENZ-FT-analyst_blog|investment_ideas-2412571">Alphabet Inc. (NASDAQ: </a><a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=CRWD&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_215_2412571_CRWD&amp;cid=CS-BENZ-FT-analyst_blog|investment_ideas-2412571">CrowdStrike (CRWD): Free Stock Analysis Report</a> 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=NET&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_215_2412571_NET&amp;cid=CS-BENZ-FT-analyst_blog|investment_ideas-2412571">Cloudflare, Inc. (NET): Free Stock Analysis Report</a>
<a href="https://www.zacks.com/stock/news/2412571/cyber-threats-escalating-globally-time-to-bet-on-crwd-net?cid=CS-BENZ-FT-analyst_blog|investment_ideas-2412571">To read this article on Zacks.com click here.</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

Tech

AMZN

GOOGL

MSFT

Cyber Threats Escalating Globally: Time to Bet on CRWD & NET?

On Saturday, 4D Molecular Therapeutics&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) announced initial interim 52-week data from the Phase 2b Population Extension cohort of the PRISM trial of 4D-150 in a broad wet age-related macular degeneration (wet AMD) patient population.
Additional data were provided on the durability of aflibercept expression <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43579183/4dmt-presents-positive-52-week-results-from-phase-2b-cohort-of-prism-wet-amd-study-and-long-term-d" rel="noreferrer noopener">for up to two years</a>.
Topline 52-Week Efficacy Results for 4D-150 3E10 vg/eye (Planned Phase 3 Dose) from Phase 2b Population Extension Cohort of PRISM (Data Cut-Off January 15, 2025):
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40945849/4d-molecular-therapeutics-stock-falls-after-follow-up-data-from-mid-stage-study-of-vision-loss-dr" rel="noreferrer noopener">4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate</a>
In a subgroup of 30 patients who received supplemental injections of Regeneron Pharmaceuticals Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) Eylea (aflibercept), an 83% reduction in injection burden was observed. This represents 0.97 mean supplemental injections per patient over 52-weeks vs. 6.0 injections projected with on-label aflibercept 2 mg Q8W.
<ul>
<li>70% required 0-1 supplemental injection, and 57% were injection-free through 52 weeks.</li>
<li>Improved and maintained best corrected visual acuity (BCVA) of +2.2 letters.</li>
<li>Durable central subfield thickness (CST) improved with fewer fluctuations, as measured by optical coherence tomography (OCT), of -11 µm; -13 µm in supplemental injection-free patients.</li>
</ul>
In the recently diagnosed subgroup, 87% required 0-1 supplemental injection, and 80% were injection-free through 52 weeks.
<ul>
<li>A 94% reduction in injection burden was observed over 52 weeks vs. 6.0 injections projected with on-label aflibercept 2 mg Q8W</li>
<li>Improved and maintained BCVA of +3.1 letters</li>
<li>Durable CST improvement with fewer fluctuations, as measured by OCT, of -10 µm; -20 µm in supplemental injection-free patients</li>
</ul>
4D-150 continues to be well tolerated during up to three years of follow-up in all patients treated with 3E10 vg/eye
No 4D-150–-related hypotony, endophthalmitis, vasculitis, occlusive/non-occlusive retinal vasculitis, or choroidal effusions have been observed to date
4D-150 Program Milestones
<ul>
<li>4FRONT-1 and 4FRONT-2 Phase 3 trials are expected to initiate in Q1 and Q3 2025, respectively.</li>
<li>Two-year Phase 1/2a and 18-month Phase 2b PRISM data are expected in Q4 2025.</li>
<li>Primary endpoint 52-week topline data from both 4FRONT-1 and 4FRONT-2 expected in H2 2027.</li>
</ul>
Price Action: FDMT stock is down 8.54% at $5.46 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/02/43593007/rivian-commercial-van-now-available-for-fleets-nationwide-in-us" target="_blank" rel="noreferrer noopener">Rivian Commercial Van Now Available For Fleets Nationwide In US</a></li>
</ul>

Comments

Open Door

Open Door (OTC:OPNDF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga